rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1993-6-29
|
pubmed:abstractText |
Pradimicins T1 and T2, new members of the pradimicin family of antibiotics, were produced by an actinomycete strain AA3798. Pradimicin T1 exhibited potent activity against a wide spectrum of fungi in vitro and demonstrated efficacy against systemic Candida albicans and Aspergillus fumigatus infections in mice.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-8820
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
589-97
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:8501001-Actinomycetaceae,
pubmed-meshheading:8501001-Animals,
pubmed-meshheading:8501001-Anthracyclines,
pubmed-meshheading:8501001-Antibiotics, Antineoplastic,
pubmed-meshheading:8501001-Antifungal Agents,
pubmed-meshheading:8501001-Aspergillosis,
pubmed-meshheading:8501001-Candidiasis,
pubmed-meshheading:8501001-Fermentation,
pubmed-meshheading:8501001-Male,
pubmed-meshheading:8501001-Mice,
pubmed-meshheading:8501001-Mice, Inbred ICR,
pubmed-meshheading:8501001-Microbial Sensitivity Tests
|
pubmed:year |
1993
|
pubmed:articleTitle |
Pradimicins T1 and T2, new antifungal antibiotics produced by an actinomycete. I. Taxonomy, production, isolation, physico-chemical and biological properties.
|
pubmed:affiliation |
Bristol-Myers Squibb Research Institute, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|